Ikris Pharma Network

Reporting Adverse Event

Patient safety is our highest priority. Continuous monitoring of medicine safety helps ensure that treatments remain safe and effective for patients. If an adverse drug event (ADE) or any unexpected reaction is suspected with a medicine facilitated through us, it should be reported promptly. Reporting adverse events supports accurate safety monitoring and helps improve patient care. Patients are advised to seek medical advice from their treating healthcare provider for any adverse event. Patients participating in a clinical trial should report the event directly to their coordinating study site, as per trial protocol.

How to Report an Adverse Drug Event: Adverse Drug Events must be reported using the Adverse Event Reporting Form, which is to be completed by a registered healthcare professional only. You may download the form and submit it using any of the following methods: Submit the completed form to an authorized Ikris Pharma Network representative, or Send the completed form by post to the Pharmacovigilance Department with the subject line “ADE Reporting” at: Ikris Pharma Network 905, I-Thum Business Park, Plot No. 40, Block A, Unit No. 5, Tower A, Sector 62, Noida – 201301, India OR Email the completed form to: drugsafety@ikrispharmanetwork.com All adverse event reports are handled confidentially and reviewed by our Pharmacovigilance team in accordance with Indian regulatory requirements and global pharmacovigilance standards.